Quick answer No, GHK-Cu is not an FDA-approved drug for any human therapeutic indication, and neither are BPC-157 or TB-500
Sattele or his team of medical providers will recommend a schedule based on your goals
Furthermore, phosphorylated JNK induces oxidative stress, mitochondrial membrane permeability, and dysfunction through the activation of Bax, the translocation of Bax to the mitochondria, the opening of the mitochondrial permeability transition pore, and Src-dependent inhibition of the electron transport complex
CagriSema: Fixed-dose combination of cagrilintide (long-acting amylin analog) and semaglutide (GLP-1 agonist) in a single weekly injection
Practical Implications As a practical matter, these changes to the interim list are of limited immediate consequence